| 1 |
32414131 | CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis. | 2020 May 13 |
1 |
| 2 |
32745802 | An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy. | 2020 Oct 15 |
2 |
| 3 |
30852478 | Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing. | 2019 Jan |
1 |
| 4 |
26285786 | Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade. | 2015 Nov |
1 |